Patients can benefit both financially and clinically by enrolling in ongoing clinical trials, said Eric Lander, MD.

Widespread noncompliance with federal cost-sharing rules exists, particularly impacting Medicare beneficiaries and ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

Patients were stratified into 4 risk groups based on recent heart failure hospitalization (HFH) and use of loop diuretics. 1 ...

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the ...

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients ...

Making clinical trials easier to find for clinicians and making protocols for entering clinical trials more lenient can help ...